Pizzuti Dana
SEC insider (Form 3/4/5 filer). CIK 0001948238. Chief Med and Dev Officer at Crinetics Pharmaceuticals, Inc. (CRNX). 22 reported Form 4/5 transactions since Sep 2024; latest on Dec 1, 2025. Located in SAN DIEGO, CA.
Companies Pizzuti Dana has filed insider reports for
- Crinetics Pharmaceuticals, Inc. (CRNX): Officer, Chief Med and Dev Officer
Pizzuti Dana
CIK: 0001948238
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Crinetics Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Dec 1, 2025CRNX
Crinetics Pharmaceuticals, Inc.
ExerciseDirect5K shares at avg. $16.89$84K - Dec 1, 2025CRNX
Crinetics Pharmaceuticals, Inc.
SaleDirect5K shares at avg. $45.02$225K - Nov 3, 2025CRNX
Crinetics Pharmaceuticals, Inc.
SaleDirect100 shares at avg. $43.27$4K - Nov 3, 2025CRNX
Crinetics Pharmaceuticals, Inc.
ExerciseDirect5K shares at avg. $16.89$84K - Nov 3, 2025CRNX
Crinetics Pharmaceuticals, Inc.
SaleDirect4.9K shares at avg. $42.65$209K - Oct 1, 2025CRNX
Crinetics Pharmaceuticals, Inc.
SaleDirect5K shares at avg. $41.81$209K - Oct 1, 2025CRNX
Crinetics Pharmaceuticals, Inc.
ExerciseDirect5K shares at avg. $16.89$84K - Sep 2, 2025CRNX
Crinetics Pharmaceuticals, Inc.
SaleDirect5K shares at avg. $32.10$161K - Sep 2, 2025CRNX
Crinetics Pharmaceuticals, Inc.
ExerciseDirect5K shares at avg. $16.89$84K - Aug 22, 2025CRNX
Crinetics Pharmaceuticals, Inc.
ExerciseDirect30K shares at avg. $16.89$507K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 1, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Exercise | 5,000 | $16.89 | $84,450 | Direct |
| Dec 1, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Sale | 5,000 | $45.02 | $225,100 | Direct |
| Nov 3, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Sale | 100 | $43.27 | $4,327 | Direct |
| Nov 3, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Exercise | 5,000 | $16.89 | $84,450 | Direct |
| Nov 3, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Sale | 4,900 | $42.65 | $208,985 | Direct |
| Oct 1, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Sale | 5,000 | $41.81 | $209,050 | Direct |
| Oct 1, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Exercise | 5,000 | $16.89 | $84,450 | Direct |
| Sep 2, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Sale | 5,000 | $32.10 | $160,500 | Direct |
| Sep 2, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Exercise | 5,000 | $16.89 | $84,450 | Direct |
| Aug 22, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Exercise | 30,000 | $16.89 | $506,700 | Direct |
1-10 of 22 transactions